Cockayne Syndrome (CS) is a rare congenital disease that causes photosensitivity, growth and mental retardation, impaired nervous system development and premature ageing. The syndrome displays a complex array of symptoms that are caused by mutations in the CSB, or CSA gene, respectively, which facilitate DNA damage recognition in transcription-coupled nucleotide excision repair (TC-NER). While CS mouse models are photosensitive, and have been important for understanding some of the clinical features observed in humans, they lack concrete evidence for neurodegeneration. Here, we present evidence of neuronal and mitochondrial aberrations in
csb-1(
ok2335) mutant worms, which can be rescued by transgenic expression of pcsb-1CSB-1::GFP. Neurodegeneration manifests progressively and is paralleled by neuro-muscular functional decline substantiated by reduced pharyngeal pumping, locomotion, touch sensation and chemosensation abilities, which are further enhanced upon UVB-induced DNA damage or transcription-blocking lesions caused by the cytotoxin Illudin M. The
csb-1 mutant shows the accumulation of dysfunctional mitochondria, and increased hyperfusion, which is exacerbated upon exposure to UVB, resulting in reduced respiratory activity. Our data support the causal role of endogenous DNA damage for neurodegeneration and mitochondrial dysfunction in CS, and warrants the use of the model for identifying pharmacological interventions to improve CS and ageing.